My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Novo Nordisk A/S Common Stock (NY:NVO)

48.10 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 22, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novo Nordisk A/S Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

Should You Invest $1,000 in Eli Lilly today? ↗

June 05, 2025

Via The Motley Fool

What's Going On With Novo Nordisk Shares Today? ↗

June 03, 2025

Shares of Novo Nordisk Inc. (NYSE: NVO) are trading lower Tuesday after a new study raised concerns about a potential link between GLP-1 weight loss drugs like Ozempic and an increased risk of kidney...

Via Benzinga

Florida Rep. Scott Franklin Bought Up to $15K Worth of Union Pacific Stock ↗

June 03, 2025

Via Benzinga

Regeneron's Obesity Trial With Novo Nordisk's Wegovy Hits Lean Target ↗

June 02, 2025

Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies aim to reduce.

Via Benzinga

NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) – A Strong Growth Stock with Reasonable Valuation ↗

May 31, 2025

NOVO-NORDISK (NYSE:NVO) offers strong growth, solid profitability, and reasonable valuation, making it a compelling choice for investors seeking affordable growth stocks.

Via Chartmill

3 Health Care Stocks With Whale Alerts In Today's Session ↗

May 30, 2025

Via Benzinga

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial ↗

May 28, 2025

Via Benzinga

2 Top Stocks to Buy With Less Than $100 ↗

May 30, 2025

Via The Motley Fool

2 Beaten-Down Stocks to Buy on the Dip ↗

May 30, 2025

Via The Motley Fool

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly ↗

May 29, 2025

Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?

Via Investor's Business Daily

NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) – A Strong Candidate for Value Investors ↗

May 28, 2025

NOVO-NORDISK (NYSE:NVO) offers strong profitability, solid growth, and reasonable valuation, making it a compelling choice for value investors. Its financial health and industry-leading margins add...

Via Chartmill

Novo Nordisk's 52% Plunge: Is the Company Fumbling Its Leadership in the $150 Billion Weight Loss Market? ↗

May 28, 2025

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

May 27, 2025

Via Benzinga

3 Surprising Stocks That Have More Than Doubled in 2025 ↗

May 27, 2025

Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would have predicted.

Via The Motley Fool

Topics Government

Why Novo Nordisk Stock Just Popped ↗

May 27, 2025

President Trump has good news for Novo Nordisk investors, and more may be on the way.

Via The Motley Fool

Topics Government World Trade

"If Walmart Is Under Pressure to Raise Prices, It's Going to Have Broader Effects on the Economy." ↗

May 27, 2025

Via The Motley Fool

Topics Earnings Economy World Trade

8 Health Care Stocks With Whale Alerts In Today's Session ↗

May 23, 2025

Via Benzinga

Analysts Think These Stocks Could More Than Double in Value

May 23, 2025

Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.

Via MarketBeat

Topics World Trade

Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dull ↗

May 22, 2025

Truist noted on Thursday that the $200/month price point is "highly attractive compared to other price points in the market," including Hims & Hers' compounded Semaglutide, Wegovy, and Liraglutide...

Via Stocktwits

Novo Nordisk To Sell Wegovy For $199 A Month As Compounding Ban Nears: Retail’s Bullish ↗

May 22, 2025

The offer will be valid through June 30 and aims to encourage patients who previously used compounded versions of the drug to move to Wegovy.

Via Stocktwits

Did Eli Lilly Just Say Checkmate to Novo Nordisk? ↗

May 22, 2025

Via The Motley Fool

Wegovy, Zepbound Just Got Cheaper: Cigna Sets $200 Monthly Limit For Weight-Loss Drug Users ↗

May 22, 2025

Cigna’s Evernorth has reached agreements with Eli Lilly and Novo Nordisk to reduce prices for GLP-1 weight-loss drugs Wegovy and Zepbound

Via Stocktwits

Best Healthcare Stocks: Eli Lilly vs. Novo Nordisk ↗

May 21, 2025

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 20, 2025

Via Benzinga

Why Novo Nordisk Stock Popped on Tuesday ↗

May 20, 2025

If you can't beat Novo Nordisk, maybe you should join 'em?

Via The Motley Fool

2 Fantastic Beaten-Down Growth Stocks Down 40% and 45% to Buy ↗

May 20, 2025

These two stocks are poised for near-term and long-term upside.

Via The Motley Fool

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants ↗

May 19, 2025

is it the end of the diabetes industry? Here's a small cap that could upend the business models of pharma giants...

Via Benzinga

MarketBeat Week in Review – 05/12 - 05/16

May 17, 2025

Stocks had a strong week on a potential U.S.-China trade deal and cooler inflation data, but volatility may remain as investors shift focus to tax cuts

Via MarketBeat

Topics Artificial Intelligence Economy Government

NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) – A Strong Growth Stock with Technical Breakout Potential ↗

May 17, 2025

NOVO-NORDISK (NYSE:NVO) is a strong growth stock with solid fundamentals and a promising technical setup, offering potential for a breakout.

Via Chartmill

On Holding on Fire ↗

May 17, 2025

A consumer goods company hit 40% yearly revenue growth. In this environment?

Via The Motley Fool

Topics Bonds Government

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.